IP Library Granted Patent US 7,676,386
Granted Patent B2
US 7,676,386 · App. 11/644,302 · Granted Mar 9, 2010

Systems and methods for scheduling and sequencing sessions or appointments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,676,386
App. No.
11/644,302
Granted
Mar 9, 2010
Kind
B2
Abstract

Embodiments of the present invention provide systems and methods for scheduling patients in an organized and uniform way using a batch follow-up system. Such batch follow-up methods help a research site conducting research to prepare one or more of study supplies, patient charts, study goals, and data collecting requirements in preparation for the batch follow-up visits. Embodiments of the invention also relate to systems and methods for communicating initial and follow-up visit dates to patients. In certain instances, various communications (e.g., between the patients and the study site or between the study site and the study sponsor) may be electronic communications. Methods of scheduling and sequencing patient visits may be conducted over a network wherein reminders about follow-up visits are electronically generated.

Claims (40)

1. A method for scheduling batch follow-up visits for a plurality of patients participating in a clinical trial, comprising:

(a) determining a number of follow-up visits after an initial visit for each patient of the plurality of patients participating in the clinical trial conducted at a research site;

(b) identifying a first follow-up visit date for a first follow-up batch visit for each patient of the plurality of patients, the first follow-up visit date for each patient of the plurality of patients being within a first time window, wherein the first follow-up visit date is after the initial visit;

(c) batch scheduling, by a processor-based device, the first follow-up batch visit for the plurality of patients by scheduling the first follow-up batch visit for each patient of the plurality of patients to occur in the first time window;

(d) identifying a second follow-up visit date for a second follow-up batch visit for each patient of the plurality of patients, the second follow-up visit date for each of patient of the plurality of patients being within a second time window, wherein the second follow-up visit date is after the first follow-up visit date;

(e) batch scheduling, by the processor-based device, the second follow-up batch visit for the plurality of patients by scheduling the second follow-up batch visit for each patient of the plurality of patients to occur in the second time window; and

wherein the first time window and second time window are separated by at least one week.

2. The method of claim 1 , wherein the initial visit, first follow-up batch visit, and second follow-up batch visit for the plurality of patients are associated with the clinical trial.

3. The method of claim 1 , further comprising communicating the batch scheduled first follow-up visit date and batch scheduled second follow-up visit date to each patient of the plurality of patients.

4. The method of claim 3 , wherein the communication is electronic.

5. The method of claim 1 , wherein the method is used by a research site conducting research, and wherein the research site is able to prepare one or more of study supplies, patient charts, study goals, and data collecting requirements in preparation for at least one of the first follow-up batch visit or the second follow-up batch visit for the plurality of patients.

6. The method of claim 1 , wherein the first time window and second time window each comprise one of: one day, one week, or one month.

7. The method of claim 1 , further comprising:

electronically generating a reminder for the first follow-up batch visit for the plurality of patients; and

providing the reminder to each patient of the plurality of patients over a network.

8. The method of claim 1 , wherein the nature of the first follow-up batch visit and the second follow-up batch visit for the plurality of patients relates to a protocol of the clinical trial.

9. The method of claim 1 , further comprising:

scheduling a first emergency visit between the initial visit and the first time window, wherein the first emergency visit comprises a first unscheduled visit by at least one of the plurality of patients.

10. The method of claim 1 , wherein the initial visit occurs at a different time for each patient of the plurality of patients.

11. A system for scheduling a plurality of patients participating in a clinical trial by a batch scheduling process after an initial visit by each of the plurality of patients, the system comprising:

a research site device comprising a processor capable of executing program code stored on computer-readable media, the research site device being configured to execute the program code to:

determine a number of follow-up visits after an initial visit by each patient of the plurality of patients participating in the clinical trial conducted at a research site;

batch schedule a first follow-up batch visit for each patient of the plurality of patients, the first follow-up batch visit for each patient of the plurality of patients being batch scheduled for a first follow-up visit date to occur in a first time window; and

batch schedule a second follow-up batch visit for each patient of the plurality of patients, the second follow-up batch visit for each patient of the plurality of patients being batch scheduled for a second follow-up visit date to occur in a second time window,

wherein the first time window and the second time window are configured to be separated by at least one week.

12. The system of claim 11 , wherein the first follow-up batch visit and the second follow-up batch visit for the plurality of patients are associated with the clinical trial.

13. The system of claim 11 , wherein the research site device is configured to provide the first follow-up visit date and the second follow-up visit date to the plurality of patients over a network.

14. The system of claim 11 , wherein the first time window and the second time window each comprises one of: one day, one week, or one month.

15. The system of claim 11 , wherein the first time window and the second time window are a condensed time span.

16. The system of claim 11 , wherein the research site device is configured to generate a reminder for at least one of the first follow-up visit date or the second follow-up visit date for the plurality of patients and provide the reminder to each of the plurality of patients over a network.

17. A method for scheduling a plurality of patients participating in a clinical trial in batches, the method comprising:

identifying a first time window in which to schedule a first follow-up batch visit for all of the plurality of patients to occur in a first batch, the first batch to be conducted during the first time window;

identifying a second time window in which to schedule a second follow-up batch visit for all of the plurality of patients to occur in a second batch, the second batch to be conducted during the second time window;

scheduling the first follow-up batch visit for each patient of the plurality of patients to occur in the first time window; and

scheduling the second follow-up batch visit for each patient of the plurality of patients to occur in the second time window.

18. The method of claim 17 , wherein the first time window and the second time window are at least one of: one hour, one day, or one week.

19. The method of claim 1 , wherein the first time window and second time window each comprise one month; and

wherein the first time window and the second time window are separated by at least ninety days.

20. The system of claim 11 , wherein the first time window and the second time window comprise one month; and

wherein the first time window and the second time window are configured to be separated by at least ninety days.

Assignments (17)
SECURITY INTEREST Recorded Mar 12, 2026
From: IMS SOFTWARE SERVICES LTD.; IQVIA INC.; IQVIA RDS INC.; RULES-BASED MEDICINE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075047/0061 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTIES INADVERTENTLY NOT INCLUDED IN FILING PREVIOUSLY RECORDED AT REEL: 065709 FRAME: 618. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 6, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065790/0781 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065710/0253 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065709/0618 →
SECURITY INTEREST Recorded May 24, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063745/0279 →
CHANGE OF NAME Recorded Oct 9, 2018
From: QUINTILES IMS INCORPORATED
To: IQVIA INC.
Reel/Frame 047207/0276 →
MERGER AND CHANGE OF NAME Recorded Sep 5, 2018
From: QUINTILES TRANSNATIONAL CORP.; IMS HEALTH INCORPORATED
To: QUINTILES IMS INCORPORATED
Reel/Frame 046787/0726 →
SECURITY AGREEMENT Recorded Oct 4, 2016
From: QUINTILES IMS INCORPORATED
To: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 040222/0798 →
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2016
From: JPMORGAN CHASE BANK, N.A.
To: ENCORE HEALTH RESOURCES, LLC; EXPRESSION ANALYSIS, INC.; OUTCOME SCIENCES, LLC; QUINTILES TRANSNATIONAL CORP.; QUINTILES, INC.; QUINTILES MARKET INTELLIGENCE, LLC; TARGETED MOLECULAR DIAGNOSTICS, LLC
Reel/Frame 039925/0352 →
SECURITY AGREEMENT Recorded May 14, 2015
From: QUINTILES TRANSNATIONAL CORP.; ENCORE HEALTH RESOURCES, LLC; OUTCOME SCIENCES, LLC; QUINTILES, INC.; QUINTILES MARKET INTELLIGENCE, LLC; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 035664/0180 →
RELEASE OF SECURITY INTEREST Recorded May 13, 2015
From: JPMORGAN CHASE BANK, N.A.
To: QUINTILES TRANSNATIONAL CORP.; TARGETED MOLECULAR DIAGNOSTICS, LLC; QUINTILES, INC.; OUTCOME SCIENCES, INC.; EXPRESSION ANALYSIS, INC.; ENCORE HEALTH RESOURCES, LLC
Reel/Frame 035655/0392 →
SECURITY AGREEMENT Recorded Jun 9, 2011
From: QUINTILES TRANSNATIONAL CORP.; QUINTILES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: JPMORGAN CHASE BANK, NA, AS ADMINISTRATIVE AGENT
Reel/Frame 026413/0611 →
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2011
From: CITICORP NORTH AMERICA, INC., AS AGENT
To: QUINTILES TRANSNATIONAL CORP.; TARGETED MOLECULAR DIAGNOSTICS, LLC
Reel/Frame 026410/0695 →
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2011
From: CITICORP NORTH AMERICA, INC., AS AGENT
To: QUINTILES TRANSNATIONAL CORP.; TARGETED MOLECULAR DIAGNOSTICS, LLC
Reel/Frame 026410/0799 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Apr 21, 2009
From: QUINTILES TRANSNATIONAL CORP.; EIDETICS, INC.; QUINTILES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: CITICORP NORTH AMERICA, INC., AS COLLATERAL AGENT
Reel/Frame 022570/0319 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Apr 20, 2009
From: QUINTILES TRANSNATIONAL CORP.; EIDETICS, INC.; QUINTILES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: CITICORP NORTH AMERICA, INC., AS COLLATERAL AGENT
Reel/Frame 022568/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2009
From: STEPHENSON, HUGO
To: QUINTILES TRANSNATIONAL CORP.
Reel/Frame 022446/0634 →